Data / Form D filings / Genomic Cancer Institute, Inc.
Genomic Cancer Institute, Inc.: Form D filing
Genomic Cancer Institute, Inc., a health care company in Tampa, FL, filed a Form D with the SEC in 2016. The latest, on January 8, 2016, reports an offering of $1.5 million with nothing sold yet.
Find out what Genomic Cancer Institute, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 403 EAST MADISON STREET, SUITE 400, Tampa, FL, 33602
- Phone
- (813) 225-2500
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Florida
- Year incorporated
- 2015
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1663181
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 8, 2016 | New notice | $1,499,999 | $0 | $1,499,999 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Garry Latimer | Executive Officer, Director | |
| Matthew Miller | Executive Officer, Director | |
| Robert Francis | Director | |
| John Sauickie | Executive Officer, Director | |
| Steve Gorlin | Director |
Other health care companies in Florida that filed recently
- PulsePoint Lake Norman ASC, LLC offering · Nov 4, 2026
- Lev 18, Inc. $250,000 · Oct 9, 2026
- Coast Medical Innovations, LLC $550,000 · Oct 8, 2026
- Metabolica, Inc. offering · Oct 7, 2026
- Colonial Outpatient Surgery Center, LLC $915,156 · Sep 30, 2026
- VIRGO CAPITAL PARTNERS, LLC offering · Sep 17, 2026
- Prosper Health, Inc. $10 million · Sep 10, 2026
- PulsePoint EP, LLC offering · Sep 8, 2026
- Klothea Bio, Inc. $6.9 million · Sep 8, 2026
- JUPITER NEUROSCIENCES, INC. $774,787 · Sep 4, 2026
- Nexus Bedside, Inc. $6.3 million · Aug 27, 2026
- Alden Advanced Technologies, Inc. $1.4 million · Aug 20, 2026
Every Form D from the week of Jan 4, 2016 · All recent filings in Florida · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Genomic Cancer Institute, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.